RESEARCH-USE BIOSIMILAR ANTIBODY
Lesabelimab
Monoclonal antibody · IgG1
Lesabelimab (LDP) is an immunoglobulin G1-kappa anti-CD274 monoclonal antibody. CD274 is an immune checkpoint ligand, represses antitumour immunity through the interaction with PDCD1 receptor.
TARGETPDL1
YMonoclonal antibody
CATALOGSC-BS-427
CATALOG NUMBERSC-BS-427
MOLECULAR WEIGHTApprox. 144.76 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Lesabelimab (LDP) is an immunoglobulin G1-kappa anti-CD274 monoclonal antibody. CD274 is an immune checkpoint ligand, represses antitumour immunity through the interaction with PDCD1 receptor.
Lesabelimab is a recombinant research-use antibody directed against PDL1.